Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load
Year: 2025
Type: article
Language: en
Topic: Multiple Myeloma Research and Treatments
Authors and affiliations:
raw_author_name: Cathelijne Fokkema
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer Institute, Rotterdam, Netherlands
raw_author_name: Luca Bertamini
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer Institute, Rotterdam, Netherlands
raw_author_name: Madelon M. E. de Jong
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer institute, Rotterdam, Netherlands
raw_author_name: Sabrin Tahri
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer Institute, Rotterdam, Netherlands
raw_author_name: Davine Hofste op Bruinink
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer Institute, Rotterdam, Netherlands
raw_author_name: Zoltan Kellermayer
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer Institute, Rotterdam, Netherlands
raw_author_name: Natalie Papazian
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC, Rotterdam, Netherlands
raw_author_name: Chelsea den Hollander
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer Institute, Rotterdam, Netherlands
raw_author_name: Michael P. W. Vermeulen
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer Institute, Rotterdam, Netherlands
raw_author_name: Elodie C. G. Stoetman
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer Institute, Rotterdam, Netherlands
raw_author_name: Gregory van Beek
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer Institute, Rotterdam, Netherlands
raw_author_name: Remco Hoogenboezem
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer institute, Rotterdam, Netherlands
raw_author_name: Vincent H. J. van der Velden
raw_affiliation_strings: 2Department of Immunology, Erasmus MC, Rotterdam, The Netherlands
Erasmus MC, Rotterdam, Netherlands
raw_author_name: Cyrille Hulin
raw_affiliation_strings: 3Hematology Unit, Haut Leveque Hospital, University Hospital Bordeaux, Bordeaux, France
CHU Bordeaux, Hopital haut Leveque, centre François Magendie, PESSAC, France
raw_author_name: Aurore Perrot
raw_affiliation_strings: 4Hematology Department, Toulouse University Hospital, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
Université de Toulouse, CHU Toulouse, Toulouse, France
raw_author_name: Philippe Moreau
raw_affiliation_strings: 5Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
Hematology, University Hospital Hôtel-Dieu, Nantes, France
raw_author_name: Melissa Rowe
raw_affiliation_strings: 6Johnson & Johnson, High Wycombe, United Kingdom
Johnson & Johnson, High Wycombe, UK, United Kingdom
raw_author_name: Diego Vieyra
raw_affiliation_strings: 7Janssen Research & Development, Spring House, PA
Janssen Research & Development, LLC, Spring House, Pennsylvania, United States
raw_author_name: Robin Carson
raw_affiliation_strings: 6Johnson & Johnson, High Wycombe, United Kingdom
Johnson & Johnson, High Wycombe, UK, United Kingdom
raw_author_name: Mark van Duin
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer institute, Rotterdam, Netherlands
raw_author_name: Mathijs A. Sanders
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer institute, Rotterdam, Netherlands
raw_author_name: Annemiek Broijl
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer Institute, Rotterdam, Netherlands
raw_author_name: Pieter Sonneveld
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer institute, Rotterdam, Netherlands
raw_author_name: Tom Cupedo
raw_affiliation_strings: 1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus MC Cancer Institute, Rotterdam, Netherlands